
Loading, please wait...

Loading, please wait...

Cystic lesions of the ovaries represent a frequent clinical finding in adolescent girls, often presenting as incidental discoveries during routine examinations or as acute pelvic pain. While the majority of these lesions are functional and benign, a subset can grow to an extraordinary size, occupying the entire abdominopelvic cavity. Effective giant ovarian cyst management requires a specialized approach that balances oncological safety with the preservation of future reproductive potential. In adolescents, the psychological and physiological impact of surgical intervention is significant, necessitating a multidisciplinary team comprising pediatric surgeons, gynecologists, and radiologists. Recent clinical data underscores the importance of rapid diagnostic protocols and tailored surgical interventions to manage these rare but complex cases successfully. By prioritizing organ-preserving techniques and utilizing advanced imaging, clinicians can achieve favorable outcomes even when faced with massive adnexal masses that mimic malignancy.
The clinical presentation of giant ovarian cysts in the adolescent population can be remarkably diverse, often leading to diagnostic delays. Many patients remain asymptomatic until the lesion reaches a size where it causes visible abdominal distension or compression of adjacent organs. Patients frequently report vague symptoms such as bloating, early satiety, or a gradual increase in waist circumference, which may be misattributed to weight gain or gastrointestinal issues. However, acute presentations can occur if the cyst undergoes torsion, rupture, or intracystic hemorrhage, leading to severe abdominal pain and signs of peritonitis. Consequently, clinicians must maintain a high index of suspicion when an adolescent presents with a palpable abdominal mass or unexplained distension. Furthermore, the physical examination is often insufficient to distinguish between different types of adnexal masses. Therefore, a standardized diagnostic workflow is essential. This includes a thorough medical history, physical examination, and a detailed review of menstrual patterns. In many cases, the sheer size of the lesion complicates the initial assessment, as it may be difficult to determine the organ of origin. Nevertheless, early identification is critical to prevent complications such as ovarian torsion, which can lead to irreversible ischemic damage and loss of the affected ovary. Accurate diagnosis at this stage sets the foundation for successful surgical planning.
Once a giant adnexal mass is suspected, imaging becomes the cornerstone of the diagnostic process. Abdominal ultrasound is typically the first-line modality due to its accessibility and lack of ionizing radiation. It provides essential information regarding the cystic or solid nature of the mass and the presence of internal septations or papillary projections. However, for giant lesions, ultrasound often fails to visualize the entire extent of the mass or its relationship with surrounding vascular structures. Consequently, abdominopelvic magnetic resonance imaging (MRI) is considered the gold standard for further characterization. MRI offers superior soft-tissue contrast and can help differentiate between benign pathologies, such as mature cystic teratomas, and more concerning features suggestive of malignancy. In addition to imaging, the assessment of serum tumor markers is mandatory. Markers such as Alpha-fetoprotein (AFP), Beta-human chorionic gonadotropin (Beta-hCG), Lactate dehydrogenase (LDH), and Cancer Antigen 125 (CA-125) provide vital clues. While CA-125 can be elevated in benign conditions like endometriosis or torsion, extremely high levels combined with complex imaging findings may indicate an epithelial or germ cell malignancy. Therefore, integrating imaging findings with tumor marker profiles allows the surgical team to stratify the risk of malignancy and choose the most appropriate surgical approach. This comprehensive evaluation is a non-negotiable step in modern giant ovarian cyst management.
The choice between laparoscopic and open surgery for giant ovarian cysts remains a subject of clinical debate. Historically, large masses were managed via laparotomy to minimize the risk of cyst rupture and subsequent spillage of potentially malignant cells. However, advancements in minimally invasive techniques have shifted the paradigm. Laparoscopic surgery is now frequently performed for large lesions, provided the imaging and tumor markers do not strongly suggest malignancy. The primary advantage of the laparoscopic approach includes reduced postoperative pain, shorter hospital stays, and superior cosmetic results—a factor particularly important for adolescent patients. During laparoscopy, surgeons may employ controlled aspiration of the cyst fluid within a protected environment to reduce the volume of the mass, thereby creating enough working space to complete the excision. Conversely, open surgery may still be necessary for extremely large, complex, or suspicious masses where the risk of spillage is too high. In both approaches, the ultimate goal is organ preservation. Surgeons strive to perform a cystectomy, carefully stripping the cyst wall from the healthy ovarian parenchyma, rather than a full oophorectomy. This meticulous technique is crucial for maintaining hormonal balance and future fertility. The decision-making process must be individualized, considering the surgeon's expertise, the patient's anatomy, and the specific characteristics of the lesion identified during preoperative workup.
The histopathological diversity of giant ovarian cysts in adolescents is broad, ranging from benign functional cysts to rare malignancies. A retrospective analysis of cases often reveals a variety of underlying conditions. For instance, mucinous cystadenomas are a common finding and can grow to massive proportions. While generally benign, they carry a risk of recurrence if not completely excised. More rarely, a giant lesion may be diagnosed as a mucinous adenocarcinoma. This malignancy is exceptionally uncommon in the pediatric age group and requires aggressive management, often involving the removal of the affected ovary and fallopian tube, followed by close oncological surveillance. Another frequent diagnosis is the mature cystic teratoma, or dermoid cyst, which contains tissues from multiple germ layers such as fat, hair, and bone. In some instances, the underlying cause of a giant cystic mass is not a neoplasm but rather massive fluid accumulation secondary to chronic or intermittent ovarian torsion. This variety in histopathology highlights why surgical planning cannot rely on imaging alone. Each case must be approached with the understanding that the definitive diagnosis will only be confirmed postoperatively. Consequently, the surgical team must be prepared to adjust their strategy based on intraoperative findings, always leaning toward the most conservative option that ensures patient safety and long-term health.
Following surgical intervention, the focus of giant ovarian cyst management shifts to long-term surveillance and the preservation of reproductive health. Patients who undergo organ-preserving surgery require regular follow-up with ultrasound to monitor for recurrence, especially in cases of mucinous cystadenomas or teratomas. In the Indian clinical context, managing these cases presents unique challenges, including varying levels of access to advanced imaging like MRI in rural areas. Many adolescent girls in India may present late due to socio-cultural factors or a lack of awareness regarding gynecological health. Therefore, pediatricians and general practitioners in India play a vital role in the early detection and referral of these cases to tertiary centers equipped with specialized pediatric surgical and gynecological facilities. Furthermore, the emphasis on fertility preservation is paramount in the Indian setting, where future reproductive health often carries significant social and personal weight. Implementing standardized protocols that prioritize minimally invasive and organ-sparing techniques can significantly improve the quality of life for these young patients. Education for primary care providers on the significance of palpable abdominal masses in puberty is essential to reduce the incidence of emergency surgeries and improve the rates of successful ovarian salvage.
While there is no single universal definition, most clinicians classify an ovarian cyst as \"giant\" when its diameter exceeds 10 centimeters or when it occupies more than half of the abdominal cavity. In adolescents, these masses can sometimes reach 30 centimeters or more, mimicking pregnancy or massive ascites. Their size poses a significant risk of complications such as torsion or respiratory compromise due to diaphragmatic elevation.
Yes, laparoscopy is increasingly considered safe for giant ovarian cysts if certain criteria are met. Surgeons must first rule out high-risk malignant features using MRI and tumor markers. If the risk is low, they can use controlled aspiration techniques to decompress the cyst, allowing for a minimally invasive excision. This approach significantly reduces recovery time and scarring compared to traditional open surgery, though it requires high surgical expertise.
The risk of recurrence depends heavily on the histopathological type of the cyst. For example, mucinous cystadenomas and mature cystic teratomas have a known potential for recurrence if any part of the cyst wall remains. Studies show that roughly 10% to 15% of certain benign lesions may reappear over time. Regular postoperative monitoring via ultrasound is essential to detect any new growth early and ensure the continued health of the preserved ovary.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Zvoncsár V et al. [Surgical treatment of giant ovarian cysts in adolescents]. Orv Hetil. 2026 Jul 19. doi: 10.1556/650.2026.33564. PMID: 42472439.
Golebiewski A, et al. Laparoscopic management of giant ovarian cysts in adolescents. Videosurgery and Other Miniinvasive Techniques. 2012;7(2):111-113.
British Society for Paediatric & Adolescent Gynaecology (BritSPAG). Guideline for the management of ovarian cysts in children and adolescents. 2017.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Cystic lesions of the ovaries are common in adolescent girls, yet giant cysts present unique clinical challenges. This review details the diagnostic workflow, the role of imaging and tumor markers, and organ-preserving surgical strategies for managing extremely large ovarian masses in the pediatric population.
Last week

A community survey in Blantyre, Malawi, shows that sex differences in tuberculosis immunoreactivity emerge during early adulthood, peaking at age 21 with 1.58-fold higher conversion risk in males. Tobacco and alcohol use drive community transmission, highlighting the need for targeted active case finding.
2 days back

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
2 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
2 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
2 days back

A UK Biobank study of 471,540 participants reveals that metabolic syndrome increases incident gastric cancer risk by 36% (HR=1.36). A positive trend was observed with accumulating metabolic components, with waist circumference showing the strongest association, highlighting modifiable risk targets.
3 days back